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Abstract
Background: Worldwide, Shigella causes an estimated 160 million infections and .1 million deaths annually. However,
limited incidence data are available from African urban slums. We investigated the epidemiology of shigellosis and drug
susceptibility patterns within a densely populated urban settlement in Nairobi, Kenya through population-based
surveillance.
Methods: Surveillance participants were interviewed in their homes every 2 weeks by community interviewers. Participants
also had free access to a designated study clinic in the surveillance area where stool specimens were collected from patients
with diarrhea ($3 loose stools within 24 hours) or dysentery ($1 stool with visible blood during previous 24 hours). We
adjusted crude incidence rates for participants meeting stool collection criteria at household visits who reported visiting
another clinic.
Results: Shigella species were isolated from 224 (23%) of 976 stool specimens. The overall adjusted incidence rate was 408/
100,000 person years of observation (PYO) with highest rates among adults 34–49 years old (1,575/100,000 PYO). Isolates
were: Shigella flexneri (64%), S. dysenteriae (11%), S. sonnei (9%), and S. boydii (5%). Over 90% of all Shigella isolates were
resistant to trimethoprim-sulfamethoxazole and sulfisoxazole. Additional resistance included nalidixic acid (3%),
ciprofloxacin (1%) and ceftriaxone (1%).
Conclusion: More than 1 of every 200 persons experience shigellosis each year in this Kenyan urban slum, yielding rates
similar to those in some Asian countries. Provision of safe drinking water, improved sanitation, and hygiene in urban slums
are needed to reduce disease burden, in addition to development of effective Shigella vaccines.
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Introduction
Although rates have decreased in middle-income and wealthy
nations, shigellosis remains a major public health problem in
impoverished settings because of sub-optimal sanitation and
hygiene and contaminated water supplies [1,2,3]. Annually,
Shigella is responsible for .160 million infections in developing
countries with an estimated 1.1 million deaths [3]. Most deaths
occur in children ,5 years of age [3]. Humans are the only
natural hosts of Shigella. Persons with diarrhea are primarily
responsible for transmission [4], which occurs predominantly
through the faecal-oral route via direct contact, fomites, or
contaminated food and water [5]. The low infectious dose (as few
as 10 organisms) renders Shigella highly infectious [5]. When
human feces are not properly disposed of, common houseflies,
particularly Musca domestica, may serve as vectors for transmission
[6].
Symptoms of shigellosis typically include diarrhea and/or
bloody stools with abdominal cramps and tenesmus [7]. Antimi-
crobial drugs shorten duration of illness and bacterial shedding,
and decrease morbidity and mortality [8]. Antimicrobial resistance
among Shigellae is increasing worldwide [9,10,11,12]. In sub-
Saharan Africa, repeated prolonged outbreaks of drug-resistant
Shigella have reduced antimicrobial therapeutic options and
increased cost of therapy [13].
Previous estimates of the burden of shigellosis in developing
countries may have underestimated its magnitude. Studies present
varying incidence and prevalence rates, because of divergent
methods and intrinsic disparities among the populations studied
[2,14,15,16]. Rapid urbanization in Africa and Asia has increased
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the number of residents of informal settlements who lack access to
basic sanitation and safe drinking water. Continued urbanization
in Africa will likely contribute to an even greater burden of enteric
diseases including shigellosis.
Since 2005, the Centers for Disease Control and Prevention
(CDC) and the Kenya Medical Research Institute (KEMRI) have
maintained population-based infectious disease surveillance
(PBIDS) in a geographically defined area within an urban informal
settlement in Nairobi, Kenya [17,18]. We used systematically
collected data from PBIDS to define the incidence and character-
ise the epidemiologic, clinical, and microbiologic features of
shigellosis within this population.
Methods
Study site
The urban PBIDS system is based in Kibera, a large informal
settlement (urban slum) in Nairobi, Kenya. Kibera lacks adequate
sanitation facilities; human and animal wastes drain into open
sewage runoff. Drinking water is often obtained from unregulated
vendors using illegal connections to a municipal piped water
system, a situation that facilitates contamination of water supplies.
Food is traded at unregulated outdoor markets that often lack
basic hygiene standards.
Surveillance procedures
The PBIDS procedures have been described previously [17,19].
Briefly, we conducted population-based surveillance for the
etiologies of diarrheal disease, febrile illness, pneumonia and
jaundice within two of 12 villages in Kibera: Gatwikera and west
Soweto. The average population of the surveillance area is 28,500
persons in a 0.37 km2 area (population density = 77,000 persons
per km2). The surveillance area was divided into 10 pre-defined
geographic zones roughly based on pre-existing sub-village
designations. Trained community interviewers visited enrolled
participants fortnightly from March 1, 2007 through Jan 31, 2010
and, thereafter every week collecting data on illnesses and deaths
since the previous visit. The frequency of household visits was
increased to shorten the recall period during the pandemic of
influenza A (H1N1). Shortened recall period was found to improve
accuracy of data collected during household visits [19]. Commu-
nity interviewers also encouraged participants to access, whenever
they fell ill, a free well-staffed and equipped study clinic (Tabitha
clinic) owned by Carolina for Kibera and located within 1 km of
all surveillance area residences.
Stool collection criteria
From January 1, 2007 through December 31, 2010, we
collected stool samples from consenting patients who met the
following criteria:
1. Uncomplicated diarrhea (defined as$3 loose stool within a 24-
hour period) without signs or symptoms of dehydration or
dysentery. (To minimize burden on the laboratory we sampled
a maximum of 6 stool specimens from patients with
uncomplicated diarrhea per day: 3 from patients ,5 years
old and 3 from patients $5 years old);
2. Complicated diarrhea based on the presence of symptoms or
signs of dehydration, defined as: drinking eagerly or unable to
drink or breastfeed, vomiting everything, slow skin pinch return
($2 seconds), irritability, sunken eyes, lethargy or unconscious-
ness (all patients);
3. Dysentery, defined as reported or visible blood in $1 stool
within 24 hours of clinic visit (all patients).
A case of shigellosis was defined as a patient meeting any of the
above criteria who had Shigella isolated from stool.
Laboratory procedures
We provided each consenting participant meeting the stool
collection criteria with a labelled stool container and instructions
on how to sample their stool; placing emphasis on including blood
or mucus, if present. From May 2008, patients visiting the clinic
who were unable to provide a stool sample while at the clinic were
sent home with a labelled container to collect a stool specimen. A
sample collector was then sent to the patient’s home to collect the
specimen within 4 hours after the clinic visit. Swabs of whole stool
specimens were placed in Cary-Blair transport medium, refriger-
ated at 4–8 uC then transported to the KEMRI-CDC enteric
microbiology laboratory in Kisumu from Jan 2007 to May 2009;
thereafter, stool specimens were processed in a microbiology
laboratory at the study clinic. More than 80% of specimens were
processed within 24–28 hours after collection. Specimens were
processed using standard microbiological procedures [20]. Isolates
were tested using the Kirby-Bauer disc diffusion technique [21] for
susceptibility to ampicillin, amoxicillin/clavulanic acid acid,
ceftriaxone, chloramphenical, nalidixic acid, ciprofloxacin, genta-
mycin, kanamycin, streptomycin, sulfisoxazole, tetracycline, and
trimethoprim-sulfamethoxazole. Results were interpreted accord-
ing to Clinical Laboratory Standards Institute (CLSI) guidelines
[22]. For quality control, we used Escherichia coli ATCC 25922
for growth and antimicrobial testing monitoring. We also
participated in external quality assurance protocols as provided
by the World Health Organization (WHO) and the South African
National Institute for Communicable Diseases (NICD).
Analysis
Data were analysed using SAS version 9.1 (Cary, NC). We
calculated incidence rates as the number of shigellosis cases per
100,000 person-years of observation (PYO), as described previ-
ously [18,23]. Participants included all individuals living in
consenting households within the surveillance area for a minimum
of 4 months between 1 January 2007 and 31 December 2010.
Person-years of observation were calculated by totalling person-
days for all people who met the residence requirement during each
biweekly home visit and dividing the total number of person-days
by 365.25.
In calculating crude incidence rates, we divided the number of
Shigella cases by the PYO. Our fortnightly and weekly home visit
data, provided real time health utilization data for use in assessing
what proportion of shigellosis cases were likely missed through
clinic-based diarrheal illness testing. Thus, adjusted rate calcula-
tions were based on the number of patients who met each of the
three stool sample collection criteria (from data collected during
home visits) who visited clinics other than the study clinic for their
illness; thus, they were ill enough to visit a clinic for their diarrhea
or dysentery, but no specimens would have been obtained, as
specimens were only collected and processed from patients
attending the study clinic. Similar incidence adjustment methods
based on health utilization data have been used in other recent
studies [18,24]. Thus, we divided number of residents meeting
each of the stool collection criteria on home visit who visited the
study clinic by number of residents meeting each of the same
criteria who visited any clinic for that illness. Episodes of diarrhea/
dysentery not associated with visits to any clinic were not
‘‘counted’’ in the adjustment. This proportion was then divided
into the crude rate of shigella obtained for each criterion.
The overall adjusted incidence rate was calculated by summing
the adjusted Shigella numbers for each stool collection criterion and
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dividing this sum by the total number of person years contributed
by participants in the study population (Fig. 1). These calculations
were also done by age group, gender, and by geographic zone.
For characterizing clinical features, drug susceptibility and
Shigellae species distribution, we included data for the entire study
period (1 Jan, 2007 to 31 Dec, 2010). From January, 2007,
through April, 2008, few (,5%) patients who met stool collection
criteria provided a stool sample for testing, leading to imprecise
adjusted incidence rates. Thus, we excluded data from that time
period for calculating the crude and adjusted incidence rates.
From May 2008, a sample collector was engaged to collect stool
samples from patients’ homes when patients were unable to
provide a sample at the clinic. This resulted in a fivefold increase
in the proportion of patients meeting case definitions who
provided a stool sample for stool culture, and provided more
stable numbers for rate calculations.
Logistic regression analysis was used to determine association of
clinical features and shigellosis for patients seen at the clinic.
Significant unadjusted clinical features (p,0.05) were then entered
into a multivariate model to control for confounding. We also
examined household data collected from patients confirmed to
have shigellosis for a period of one month after the clinic visit
when the diagnosis was made to assess the number of hospital-
izations and deaths
We used incidence rates from this study to project the burden of
shigellosis among the estimated 4.3 million people living in
informal settlement areas in Kenya [25]. We estimated the age
structure of persons living in informal settlements to be similar to
that in Kibera. Monthly rainfall data for each of the three years
was obtained from the National Oceanic and Atmospheric
Administration (NOAA) website specifically for Nairobi region
[26] and were used to explore possible associations with Shigella
incidence over time using Pearson correlation coefficient. P-values
,0.05 were considered significant for all statistical tests.
Ethical review
The protocol, surveillance questionnaires and consent forms
were reviewed and approved by the Ethical Review Committee at
the Kenya Medical Research Institute (protocol number 1899) and




Age and sex distribution of surveillance
participants. Between 1 May, 2008, and 31 Dec, 2010,
77,939 PYO were contributed by persons enrolled into the
surveillance system. Adults 18–34 years of age accounted for 35%
of the population under surveillance, followed by young adults 10–
17 years who accounted for 16%. Males and females contributed
equally. The highest proportion of surveillance participants were
from Zone 1; 18% followed by zone 10; 16% (Table 1).
Household interviews, clinic utilization and case
detection. Over 80% of enrolled study participants had
successful interviews during the biweekly/weekly household visits.
By year, this was distributed as follows; 78% in 2007, 74% in 2008,
83% in 2009 and 84% in 2010. During these visits, over 60% of
participants who met any of the stool collection criteria and
reported visiting any clinic, had visited Tabitha clinic (data not
shown). At Tabitha clinic, 7,449 patients met one of the three stool
collection criteria (Fig. 2). The majority, 5,545 (74%) had
uncomplicated diarrhea, 1,163 (16%) had dysentery and 741
(10%) had complicated diarrhea with dehydration (Fig. 2). Almost
half (42%) of those who had dysentery provided a stool sample
while only 543 (10%) and 61 (8%) of those who had uncompli-
cated diarrhea and complicated diarrhea with dehydration
provided a stool sample, respectively (Fig. 2). The proportion of
patients meeting any of the stool collection criteria who provided a
stool sample increased gradually with age, stabilizing at the 18–34
year age group (Fig. 3).
Shigella isolation and incidence rates. We isolated
262(24%) Shigella bacteria from 1,096 stool specimens collected
from patients meeting any of the three stool collection criteria from
1 Jan, 2007, through 31 Dec, 2010: 176 (67%) of Shigella isolates
were from patients presenting with dysentery, 83 (32%) from
patients with uncomplicated diarrhea and 3 (1%) from patients
with complicated diarrhea with dehydration (Fig. 2). For the
period; 1 May, 2008 through 31 Dec, 2010, 242 (23%) Shigella
bacteria were isolated from 976 stool specimens (data not shown)
The overall crude incidence rate of shigellosis was 287/100,000
PYO (Table 1). Crude incidence rate was highest among adults
35–49 years old (1,046/100,000 PYO). The overall adjusted
Figure 1. Formula for adjusted incidence rate calculations.
doi:10.1371/journal.pone.0058437.g001
Shigellosis in an Urban Slum in Nairobi, Kenya
PLOS ONE | www.plosone.org 3 March 2013 | Volume 8 | Issue 3 | e58437
incidence rate was 408/100,000 PYO with highest adjusted rates
in adults 35–49 years old (1575/100,000) (Table 1). Infants and
adults 50 years old and above had the lowest adjusted incidence
rates (136/100,000 and 108/100,000 respectively). Females were
more likely than males to have shigellosis, (OR: 1.52, 95% CI:
1.15–2.02). There was significant variation in crude incidence
rates by geographic location, with the rates ranging from 215/
100,000 PYO (zone 6) to 766/100000 PYO (zone 2) (p-value
,0.001) (Table 1).
Epidemiology and laboratory characteristics of shigellosis
Species distribution. Most Shigella isolates were S. flexneri
(64%) followed by S. dysenteriae (11%) S. sonnei (9%), and S. boydii
(5%). Species could not be determined for 12% of isolates; 6 (22%)
of the 27 isolates of S. dysenteriae were type 1 (Fig. 2).
Clinical features for shigellosis. Patients with dysentery
were more likely to have Shigella isolated from stool than patients
with complicated and uncomplicated diarrhea (OR: 10.77, 95%
CI: 3.33–34.87) and patients with ‘‘uncomplicated’’ diarrhea were
more likely to have evidence of shigellosis than those with a
complicated diarrheal illness (OR: 3.49, 95% CI: 1.07–11.39).
Patients with history of vomiting (OR: 0.54, 95% CI: 0.33–0.86)
were less likely to have shigellosis (Table 2).
One patient was hospitalized within 2 days of being seen at the
clinic while one patient died within 3 weeks after being diagnosed
with shigellosis at the clinic. S. flexneri was isolated from both
patients.
Drug susceptibility. Over 80% of Shigella isolates were
resistant to each of the following drugs: streptomycin, sulfisoxa-
zole, tetracycline and trimethoprim-sulfamethoxazole (Table 3).
Three (1%) isolates were resistant to ceftriaxone. Seven (3%)
isolates were resistant to nalidixic acid, of which 2 (29%) were also
resistant to ciprofloxacin (Table 3). Shigella incidence and monthly
rainfall Shigellosis cases occurred throughout the year. There were
no significant association between Shigella incidence and monthly
rainfall (Pearson correlation coefficient = 0.002, p-value = 0.99).
Table 1. Person years of observation, crude and adjusted incidence of Shigella by age category, sex, zone and year, 1 May 2008 to
31 Dec 2010, Kibera, Kenya.
Person years of observation (PYO) Incidence rates
Crude incidence/100,000 Adjusted incidence/100,000
Age category
,12 m 2,369 (3) 84 136
12–23 m 2,954 (4) 203 273
24–59 m 8,936 (11) 291 369
5–9 y 12,070 (15) 141 175
10–17 y 12,765 (16) 212 268
18–34 y 26,968 (35) 356 559
35–49 y 4,207 (5) 1046 1575
50 y+ 7,669 (10) 78 108
Sex
Males 39,090 (50) 219 306
Females 38,849 (50) 356 484
Year
2008 17,658 (23) 306 392
2009 28,892 (37) 270 363
2010 31,388 (40) 293 428
*Zone
1 13,741 (18) 393
2 9,398 (12) 766
3 2,467 (3) 446
4 2,828 (4) 601
5 7,839 (10) 370
6 8,852 (11) 215
7 5,111 (7) 274
8 10,219 (13) 391
9 5,379 (7) 316
10 12,105 (16) 256
Overall 77,939 287 408
*Adjusted incidence rates by zone not shown
doi:10.1371/journal.pone.0058437.t001
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Discussion
Our study revealed a high burden of shigellosis within a densely
populated urban slum in Kenya. The high crude incidence of
shigellosis of 0.29% was slightly higher than that reported in a
multicenter population-based study done in six developing
countries in Asia; three of the sites were rural/semi rural (in
China, Thailand, and Vietnam) and three of the sites were in
urban slums (in Bangladesh, Indonesia, and Pakistan), where the
overall unadjusted incidence of Shigella in this multicenter study
was estimated at 0.2% among patients of all ages [27]. The rates
were much higher than that seen in industrialized countries such
as the UK and US where the incidence of shigellosis is estimated at
0.027% and 0.0038% respectively [28,29].
In our study, over 20% of all stool samples yielded Shigella,
further confirming the high burden of shigellosis. Similar estimates
in other urban slums in Kenya are lacking. However, two studies
performed in rural western Kenya also found high Shigella isolation
rates of 15% and 16% of stool samples collected from patients
presenting with diarrhea or dysentery [30,31]. While we docu-
mented high rates of shigellosis in an urban slum, we do not have
conclusive evidence indicating that rates were higher than in rural
Figure 2. Flow chart illustrating distribution of diarrhea cases and shigella species isolated between 1 Jan 2007 and 31 Dec 2010 in
Kibera, Kenya.
doi:10.1371/journal.pone.0058437.g002
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areas. However, high population density coupled with grossly
inadequate sanitary facilities and unregulated water connections
with high likelihood of contamination may contribute to the high
incidence of shigellosis in this urban slum site.
As expected, patients presenting with dysentery were more likely
to have Shigella isolated from stool than patients presenting with
non-dysenteric diarrhea [30]. Like in other studies [3,32,33,34],
we found relatively low incidence of shigellosis among infants. This
may be partially explained by passive induced immunity conferred
by breastfeeding, as seen in a study conducted in Dhaka,
Bangladesh [34], but may also result from fewer opportunities
for exposure to contaminated food or water sources, especially
when compared with toddlers. According to the Kenya demo-
graphic and health survey, 2008–2009, the mean duration of
breastfeeding among Kenyan children is 21 months. It is possible
that majority of mothers in our setting breastfed for a period of at
least 1 year. Our findings of lowest incidence of shigellosis in
people $50 years old are also consistent with other studies; while
unexplained, it may relate to acquisition of protective immunity
or, perhaps, to safer hygiene and/or food preparation practices.
Females in the 35–49 year age group had a higher incidence of
shigellosis, than males in the same age group. It is not clear why
women in this age group were at increased risk of being infected
with Shigella; however, it is conceivable that they had a greater risk
of being infected by young children.
Our adjusted rates suggest that over 0.4% of people living in
urban slum settings are stricken with shigellosis annually. Like
other developing countries, Kenya is experiencing rapid urbani-
zation (.3%/year) and migrants from rural to urban areas tend to
settle in slums [35]. Extrapolating population-based incidence
rates presented in this paper to the estimated 4.3 million Kenyans
living in urban informal settlements similar to Kibera [25], we
estimate that over 17,000 cases of shigellosis occur in Kenyan
urban slums each year. Easy access to high quality health care and
a relatively small surveillance population likely account for the
occurrence of only one death related to shigellosis during the study
period. However, given global estimates of shigellosis-associated
case-fatality rates of 0.67% [3], it is reasonable to assume that
approximately 117 deaths from Shigella may occur annually in
Kenyan urban slums.
As in other developing countries S. flexneri was the most common
species of Shigella identified in our study population [3]. While this
information is important in guiding vaccine development, further
subtyping is necessary to identify the most common serotypes.
Shigella was isolated throughout the year. This may be explained
by the lack of adequate sanitary facilities and raw sewage flowing
all year round in open drainage channels to which children are
exposed potentially providing constant exposure to Shigella.
Many of the Shigella isolates were resistant to commonly
available and affordable antibiotics, consistent with findings of
previous studies from Africa [30,36,37,38,39]. Nearly all isolates
were susceptible to ceftriaxone, nalidixic acid and ciprofloxacin.
While current susceptibility to fluoroquinolone drugs is reassuring,
rapid emergence of nalidixic acid and ciprofloxacin resistance
elsewhere [10], highlights the importance of judicious use of these
drugs to preserve their effectiveness for treating severe shigellosis
and other life-threatening infections. Surveillance during the same
study period in Kibera has shown emergence of nalidixic acid-
resistant Salmonella strains [18,40], which likely heralds decreased
utility of fluoroquinolones for treating invasive salmonellosis [41].
While this study was unique in terms of its active surveillance for
shigellosis and for providing reliable basis for rate adjustments,
limitations may have led to underestimates or overestimates of the
burden of disease. Because of transport requirements to the
Kisumu laboratory, some stool specimens were processed
.24 hours after collection. Cary-Blair solution preserves viability
of Shigella [42]; however, ideally specimens should be processed
within 6 hours of collection. Thus, there may have been loss of
viable Shigella during shipping and storage.
In calculating, adjusted incidence rates, we assumed that
persons with diarrhea who reported visiting any clinic had similar
shigellosis incidence rates as those seen in the study field clinic.
This assumption could be erroneous if there was a systematic bias
in which persons with shigellosis tended to go to the designated
study clinic at different rates than persons with other causes of
diarrhea or dysentery. We believe that use of non-study field
clinics occurred primarily because the study clinic was open only
Monday-through-Friday during daylight hours; thus, we do not
think that there would be intrinsic biases in the way we adjusted
the incidence rates. We did not adjust the incidence rates based on
the proportion of patients who met the case definition and did not
Figure 3. Proportions of patients meeting the case definitions providing stool sample by age category.
doi:10.1371/journal.pone.0058437.g003
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provide a stool specimen. This is because a relatively small
proportion of patients meeting our diarrhea case definitions
provided stool specimen, which would have made further
adjustments imprecise, potentially exaggerating the adjusted
incidence rates. On the other hand, opting not to make this
adjustment likely led to underestimation of incidence rates. In
addition, patients with dysentery were more likely to provide a
stool sample for culture and sensitivity studies compared to
patients presenting with non-bloody diarrhea. This led to a higher
adjustment factor among patients with diarrhea (without dysen-
Table 2. Demographic and clinical characteristics associated with shigellosis on bivariate and multivariate analysis among patients
seen in study clinic, 1st Jan 2007 to 31st Dec 2011, Kibera.
Bivariate analysis Multivariate analysis
Characteristic N Shigella positive (%) OR CI OR CI
Age category*
,12 m 72 2 (3) Ref
12–23 m 101 7 (7) 2.13 0.52–12.93 2.36 0.47–11.85
24–59 m 216 34 (16) 4.85 1.53–27.94 5.47 1.26–23.68
5–9 y 117 20 (17) 5.47 1.63–31.88 6.10 1.36–27.38
10–17 y 122 29 (24) 8.16 2.52–47.28 9.34 2.12–41.14
18–34 y 297 115 (39) 16.08 5.32–91.94 17.51 4.15–73.89
35–49 y 136 49 (36) 14.57 4.63–83.91 15.84 3.66–68.55
50 y+ 35 6 (17) 6.12 1.38–38.00 6.64 1.24–35.70
Sex*
Male 526 105 (20) Ref Ref
Female 570 157 (28) 1.52 1.15–2.02 1.47 1.68–2.00
Vomiting**
No 532 126 (24) Ref
Yes 168 24 (14) 0.54 0.33–0.86 — —
Reported fever
No 406 87 (21) Ref
Yes 311 65 (21) 0.97 0.67–1.39 — —
Duration of diarrhea
Less than 3 days 594 156 (26) Ref
3–5 days 398 86 (22) 0.77 0.58–1.05 — —
6–9 days 69 11 (16) 0.53 0.27–1.04 — —
10 days and more 22 4 (18) 0.62 0.21–1.87 — —
Belly pain
No 132 36 (27) Ref
Yes 542 175 (32) 1.27 0.83–1.94 — —
Headache
No 265 79 (30) Ref
Yes 154 43 (28) 0.91 0.59–1.42 — —
Muscle pain
No 378 104 (28) Ref
Yes 35 13 (37) 1.56 0.76–3.20 — —
Case presentation*
Complicated diarrhea with dehydration 61 3 (5) Ref Ref
Uncomplicated diarrhea 543 83 (15) 3.49 1.07–11.39 1.73 0.51–5.85
Dysentery 492 176 (36) 10.77 3.33–34.87 5.32 1.59–17.86
HIV status
Negative 313 105 (34) Ref
Positive 100 33 (33) 0.98 0.60–1.57 — —
Totals 1,096 262
*Significant variables on bivariate analysis included into multivariate model
**Significant characteristics on bivariate analysis but not significant on multivariate model hence excluded from final multivariate model
doi:10.1371/journal.pone.0058437.t002
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tery), which may over estimate the burden of shigellosis in this
category of patients.
Drinking water, sanitation, and hygiene improvements within
the rapidly multiplying and expanding informal settlements in
Kenya, and elsewhere in Africa, are needed to reduce the risk of
shigellosis and other enteric infections. Health education, includ-
ing a focus on hand washing with soap, provision of safe drinking
water and proper waste disposal are feasible strategies for
containing the burden of shigellosis [43]. Given the slow progress
of improving living conditions in informal settlements, these high
incidence rates highlight the need to hasten the development of
effective vaccines to control shigellosis in resource-limited settings.
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